Chapter 290 - Disorders of Ventilation Flashcards

1
Q

arterial level of carbon dioxide is maintained between which values at sea level?

A

37 - 43 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

3 disturbances of PaCO2

A

altered CO2 production
altered minute ventilation
altered dead space fraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acute ventilatory disorders are often due to which disturbance?

A

Altered CO2 production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chronic ventilatory disorders are due to

A
  1. inappropriate levels of minute ventilation

2. increased dead space fraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Acts as the initial integration site for many of the afferent nerves relaying information about Pao2, Paco2, pH, and blood pressure from the carotid and aortic chemoreceptors and baroreceptors to the CNS

A

Dorsal Respiratory Group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where is the respiratory rhythm generated?

A

Ventral respiratory group

parafacial respiratory group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

important for the generation of active expiration

A

parafacial respiratory group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Area responsible for the generation of various forms of inspiratory activity, and lesioning of this area leads to the complete cessation of breathing

A

pre-Bötzinger complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

During normal sleep there is an attenuated response to hypercapnia and hypoxemia resulting in mild nocturnal hypoventilation that corrects upon awakening.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hypoventilation disorders result from reduced minute ventilation or increase in dead space. What are the 4 major categories?

A
  1. parenchymal lung and chest wall disease
  2. sleep disordered breathing
  3. neuromuscular disease
  4. respiratory drive disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

This is frequently a sign of reduced respiratory muscle force generation

A

New onset orthopnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Characteristic sequence of the clinical course of patients with chronic hypoventilation from neuromuscular or chest wall disease

A
  1. Asymptomatic stage
  2. Nocturnal hypoventilation
    • during REM and later in NREM
  3. Daytime Hypercapnia
    • VC drops
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hallmark of all alveolar hypoventilation syndromes

A

increase in Alveolar pCO2 and therefore in PaCO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Elevated plasma bicarbonate in the absence of volume depletion is sug- gestive of hypoventilation

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Elevated PaCO2 with a normal pH confirms what condition

A

CHRONIC alveolar hypoventilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Most frequent sleep disorder leading to chronic hypoventilation accompanied by obstructive sleep apnea

A

Obesity hypoventilation syndrome

17
Q

Which Questionnaire has been validated in the primary care setting and identifies OSA

A

Berlin Questionnaire

18
Q

Which questionnaire has been validated as a screening tool for OSA in sleep and surgical clinics.

A

STOP-Bang

19
Q

treatment of hypoventilation and apneas, both central and obstructive, in patients with neuromuscular and chest wall disorders

A

Nocturnal non-invasive positive-pressure ventilation (NIPPV)

20
Q

Criteria for using nocturnal NIPPV if symptoms of hypoventilation exist

A
  • Paco2 ≥45 mmHg
  • nocturnal oximetry ≤88% for 5 consecutive min
  • maximal inspiratory pressure <60 cmH2O
  • FVC <50% predicted
  • sniff nasal pressure <40 cmH2O.
21
Q

Pharmacologic agents that stimulate respiration, such as medroxy- progesterone and acetazolamide, have been poorly studied in chronic hypoventilation and should not replace treatment of the underlying disease process.

A

true

22
Q

Diagnostic criteria for OHS

A

BMI ≥30
chronic daytime alveolar hypoventilation (Paco2 ≥45 mmHg at sea level) in the absence of other known causes of hypercapnia.

23
Q

Treatment of OHS

A

Weight reduction

NIPPV

24
Q

OHS Treatment reserved for patients not able to tolerate high levels of CPAP support or patients that remain hypoxemic despite resolution of obstructive respiratory events

A

BIPAP

25
Q

treatment for patients with OHS but with no evidence of OSA

A

BIPAP

26
Q

Central hypoventilation syndrome presenting later in life or in the neonatal period

A

Ondine’s curse

27
Q

Abnormalities of which gene have been implicated in the pathogenesis of Congenital central hypoventilation syndrome

A

PHOX2b

28
Q

anxiety disorders and panic attacks are NOT synonymous with hyperventilation

A

True

29
Q

Once chronic hyperventilation is established, a sustained increase by how many percent in alveolar ventilation is enough to perpetuate hypocapnia?

A

10%

30
Q

Overall prevalence of OSA in middle aged men

A

3-4%

31
Q

Overall prevalence of OS in middle Ged women

A

2%

32
Q

Chest wall disease

A

A- abdominal distention
K - Kyphoscoliosis
O - Obesity

33
Q

Impaired Neuromuscular transmission

A

Myasthenia Gravis
ALS
Phrenic nerve injury
Spinal cord lesion

34
Q

Sleep disordered breathing

A

Upper airway obstruction

Intermittent hypoxemia

35
Q

Muscle weakness

A

Myopathy
Malnutrition
Fatigue

36
Q

Diminished drive

A
Sleep disordered breathing
Narcotic/ sedative use
Brainstem stroke
Hypothyroidism
Primary alveolar hypoventilation
37
Q

In how many percent of cases is sleep

Disordered breathing in the form of OSA

A

90%

38
Q

In patients with hyperventilation, an initial event leads to increased alveolar ventilation and a drop in PaCO2 to how many mmHg?

A

20mmHg

39
Q

ABG findings that can confirm chronic hyperventilation

A

Compensated Respi Alk

Near normal pH
Low PaCO2
Low HCO3